Study of Autologous Bone Marrow Derived Mononuclear Cells for Treatment of Ebstein Anomaly
Clinical trial NCT02914171 · COMPLETED
Trial details
- NCT number
- NCT02914171
- Sponsor
- Timothy J. Nelson
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2021-03-18
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.